La Belle Classe Superyachts Business Symposium: at the Yacht Club de Monaco a close look at the industry

La Belle Classe Superyachts Business Symposium: at the Yacht Club de Monaco a close look at the industry MONACO, Feb. 28, 2023 (GLOBE NEWSWIRE) — Leisure boating and sustainability to change yachting’s image. The La Belle Classe Superyachts Business Symposium organised by Yacht Club de Monaco in the form of a dinner-debate, has become a […]

Read More

Miovision Acquires MicroTraffic

Proprietary road safety analytics solution now part of the Miovision product portfolio KITCHENER, Ontario, Feb. 28, 2023 (GLOBE NEWSWIRE) — Miovision announced today that it has closed a deal to acquire Winnipeg-based MicroTraffic, a leading provider of road safety video analytics. According to a study by researchers at Toronto Metropolitan University, MicroTraffic’s proprietary approach can […]

Read More

Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases

Ad Scientiam Logo PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) — On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel digital biomarkers for the self-assessment of patients suffering from generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorders (NMOSD). The programs will leverage […]

Read More

Johnson Financial Group Selects nCino to Modernize Multiple Lines of Business

Midwest community bank moves to single platform to help ensure customer experience is at the forefront of every interaction WILMINGTON, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced that Johnson Financial Group (JFG), a privately-held financial services company and registered investment advisor, […]

Read More

Copenhagen Infrastructure Partners interconnector portfolio in the North Sea takes a leap forward

The UK-Europe interconnector portfolio (Aminth, Cronos, and Tarchon projects) has been declared eligible for Third Cap and Floor Window in the UK. COPENHAGEN, Denmark , Feb. 28, 2023 (GLOBE NEWSWIRE) — Copenhagen Infrastructure Partners’ Flagship Fund’s interconnector portfolio has officially been included amongst the short-list of projects assessed for regulatory approval in the UK, in […]

Read More

HERE and Cognizant collaborate to provide location insights and analytics for global businesses

HERE Technologies and Cognizant to work together on delivering digital customer experiences with the help of location data. This partnership provides real-time location insights and analytics to businesses across vertical industries including retail, technology, communications, manufacturing, logistics and automotive. Mumbai – HERE Technologies, the leading location data and technology platform, announced today that it has teamed up […]

Read More

Teledyne e2v releases 1.5 Megapixel version of Optimom, a turnkey optical module for quick and easy development of vision systems

Teledyne e2v’s Optimom 1.5M optical module GRENOBLE, France, Feb. 28, 2023 (GLOBE NEWSWIRE) — Teledyne e2v, a part of Teledyne Technologies [NYSE: TDY], announces the release of Optimom 1.5M, the latest member of the Optimom™ family, a new range of turnkey optical modules that can be instantly integrated into vision systems. Optimom 1.5M is a […]

Read More

Canon Medical Extends Clinically Intelligent AI-driven Enterprise Platform to include Pathology Through Partnership with Tribun Health

MINNETONKA, Minn., Feb. 28, 2023 (GLOBE NEWSWIRE) — Canon Medical Informatics, Inc. has extended its Enterprise Imaging (EI) suite of solutions to include pathology through its partnership with Tribun Health. This provides new capability for healthcare organizations to efficiently include pathology into their enterprise imaging plans as part of their precision informatics roadmaps. Canon Medical […]

Read More

Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb) Met Primary Endpoints in Two Phase 3 Clinical Studies

SHANGHAI, China, Feb. 27, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced the successful completion of two randomized, double-blind, placebo-controlled, multi-center phase III clinical studies (Study nos.: JS002-003 and JS002-006) evaluating […]

Read More
Back To Top